|
HY-135976-10mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-100mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-5mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-50mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-1mL
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-108511-10mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-100mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-25mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-5mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-50mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-B1055-100mg
|
MedChemexpress LLC
|
Pentoxyverine (citrate) [CAS 23142-01-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1055-500mg
|
MedChemexpress LLC
|
Pentoxyverine (citrate) [CAS 23142-01-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1055-1mL
|
MedChemexpress LLC
|
Pentoxyverine (citrate) [CAS 23142-01-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-134004-10mg
|
MedChemexpress LLC
|
Pentoxyverine [CAS 77-23-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134004-100mg
|
MedChemexpress LLC
|
Pentoxyverine [CAS 77-23-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134004-25mg
|
MedChemexpress LLC
|
Pentoxyverine [CAS 77-23-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134004-5mg
|
MedChemexpress LLC
|
Pentoxyverine [CAS 77-23-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134004-50mg
|
MedChemexpress LLC
|
Pentoxyverine [CAS 77-23-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134004-1mL
|
MedChemexpress LLC
|
Pentoxyverine [CAS 77-23-6] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12887-10mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-12887-25mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-12887-5mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-12887-50mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-12887-1mL
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-101676-10mg
|
MedChemexpress LLC
|
RG-12525 [CAS 120128-20-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
